Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study. [electronic resource]
Producer: 20080320Description: 500-4 p. digitalISSN:- 1095-6859
- Adenocarcinoma -- drug therapy
- Adenocarcinoma, Papillary -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cystadenocarcinoma, Serous -- drug therapy
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Middle Aged
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Oxaliplatin
- Peritoneal Neoplasms -- drug therapy
- Topotecan -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.